509 related articles for article (PubMed ID: 7670477)
1. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
[TBL] [Abstract][Full Text] [Related]
2. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
[TBL] [Abstract][Full Text] [Related]
3. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
Mancilla EE; Poggi H; Repetto G; García C; Foradori A; Cattani A
Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
[TBL] [Abstract][Full Text] [Related]
4. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.
Grigelioniené G; Hagenäs L; Eklöf O; Neumeyer L; Haereid PE; Anvret M
Hum Mutat; 1998; 11(4):333. PubMed ID: 10215410
[TBL] [Abstract][Full Text] [Related]
5. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data.
Tsai FJ; Tsai CH; Chang JG; Wu JY
Am J Med Genet; 1999 Sep; 86(3):300-1. PubMed ID: 10482885
[No Abstract] [Full Text] [Related]
7. A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia.
Stoilov I; Kilpatrick MW; Tsipouras P
Am J Med Genet; 1995 Jan; 55(1):127-33. PubMed ID: 7702086
[TBL] [Abstract][Full Text] [Related]
8. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
Naski MC; Wang Q; Xu J; Ornitz DM
Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
[TBL] [Abstract][Full Text] [Related]
9. Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia.
Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
Acta Paediatr Suppl; 1996 Oct; 417():33-8. PubMed ID: 9055906
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586
[TBL] [Abstract][Full Text] [Related]
11. A common FGFR3 gene mutation in hypochondroplasia.
Prinos P; Costa T; Sommer A; Kilpatrick MW; Tsipouras P
Hum Mol Genet; 1995 Nov; 4(11):2097-101. PubMed ID: 8589686
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
13. Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia.
Grigelioniené G; Eklöf O; Laurencikas E; Ollars B; Hertel NT; Dumanski JP; Hagenäs L
Acta Paediatr; 2000 Sep; 89(9):1072-6. PubMed ID: 11071087
[TBL] [Abstract][Full Text] [Related]
14. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characteristics of Thai patients with achondroplasia.
Shotelersuk V; Ittiwut C; Srivuthana S; Wacharasindhu S; Aroonparkmongkol S; Mutirangura A; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):429-33. PubMed ID: 11556601
[TBL] [Abstract][Full Text] [Related]
16. [Mutation analysis of fibroblast growth factor receptor 3 gene in an achondroplasia family].
Zhu B; Dong QM; Huang XH; Ji GQ; Chen Y; Wang WX; Jiang HY; Gao JS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):373-5. PubMed ID: 14556186
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in Portugal.
Almeida MR; Campos-Xavier AB; Medeira A; Cordeiro I; Sousa AB; Lima M; Soares G; Rocha M; Saraiva J; Ramos L; Sousa S; Marcelino JP; Correia A; Santos HG
Clin Genet; 2009 Feb; 75(2):150-6. PubMed ID: 19215249
[TBL] [Abstract][Full Text] [Related]
18. Achondroplasia is defined by recurrent G380R mutations of FGFR3.
Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA
Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369
[TBL] [Abstract][Full Text] [Related]
19. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
[TBL] [Abstract][Full Text] [Related]
20. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
